Left Atrial Appendage Closure With the LAmbre

NCT03147391 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2017-05-10

No results posted yet for this study

Summary

The study was to retrospectively analyse the efficacy and safety of LAA closure using the LAmbre in our center from April 2014 to November 2015.

Conditions

Interventions

DEVICE

LAA closure with LAmbre

Percutaneous Left Atrial Appendage Closure Using the LAmbre Device in Patients With Atrial Fibrillation

Sponsors & Collaborators

  • Lifetech Scientific (Shenzhen) Co., Ltd.

    collaborator INDUSTRY
  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Yawei Xu, MD, PHD · Shanghai 10th People's Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-14
Primary Completion
2016-11-30
Completion
2017-05-01

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03147391 on ClinicalTrials.gov